We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK Makes $750 Million Settlement Over Manufacturing Investigation
GSK Makes $750 Million Settlement Over Manufacturing Investigation
November 2, 2010
GlaxoSmithKline (GSK) and the Justice Department have finalized a settlement agreement in which the UK drugmaker will pay $750 million to settle an investigation into a now-shuttered Puerto Rico facility where adulterated drugs were made.